CTX130
CRISPR Therapeutics AG
Mark For: CTX130™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88296767 |
| Mark Literal Elements | CTX130 |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2019-11-12 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Domestic Representative | Jess M. Collen |
| Attorney Name | Jess M. Collen |
| Attorney Docket Number | Y485 |
| Law Office Assigned | N30 |
| Employee Name | ONUOHA, UKACHUKWU FRED |
Timeline
| 2019-02-11 | Application Filed |
| 2019-09-17 | Published |
| 2019-09-17 | Published for Opposition |
| 2019-11-12 | Location: INTENT TO USE SECTION |
| 2019-11-12 | Status: Live/Pending |
| 2019-11-12 | Transaction Date |
| 2021-04-14 | Status: A third request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  CRISPR Therapeutics AG |
| Address | Baarerstrasse 14 ZUG V8 SWITZERLAND 6300 |
| Legal Entity Type | Aktiengesellschaft |
| Legal Entity State | SWITZERLAND |
Documents
 Drawing | JPEG | 2019-02-11 |
 TEAS RF New Application | MULTI | 2019-02-11 |
| Offc Action Outgoing | XML | 2019-04-24 |
| XSearch Search Summary | XML | 2019-04-24 |
| TEAS Rev, App and/or COA of Atty/Dom.Rep | MULTI | 2019-04-26 |
| Response to Office Action | MULTI | 2019-08-01 |
| Amendment and Mail Process Complete | MULTI | 2019-08-03 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-08-07 |
| Notice of Publication | XML | 2019-08-28 |
| Notification Of Notice of Publication | XML | 2019-08-28 |
| OG Publication Confirmation | XML | 2019-09-17 |
| Notice of Allowance | XML | 2019-11-12 |
| Extension of Time to File SOU | MULTI | 2020-05-11 |
| ITU Extension Approval | XML | 2020-05-13 |
| ITU Unit Action | MULTI | 2020-05-13 |
| Change Address or Representation Form | XML | 2020-08-05 |
| Extension of Time to File SOU | XML | 2020-11-11 |
| ITU Extension Approval | XML | 2020-11-13 |
| ITU Unit Action | MULTI | 2020-11-13 |
| Change Address or Representation Form | XML | 2021-04-07 |
| Extension of Time to File SOU | XML | 2021-04-14 |
| ITU Extension Approval | XML | 2021-04-16 |
| ITU Unit Action | MULTI | 2021-04-16 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer
IC 042. US 100 101. G & S: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-04-16 | |
| TEAS EXTENSION RECEIVED | 2021-04-14 | |
| EXTENSION 3 GRANTED | 2021-04-14 | 98765 |
| EXTENSION 3 FILED | 2021-04-14 | 98765 |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-04-07 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-04-07 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-04-07 | 88888 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-11-13 | |
| TEAS EXTENSION RECEIVED | 2020-11-11 | |
| EXTENSION 2 GRANTED | 2020-11-11 | 98765 |
| EXTENSION 2 FILED | 2020-11-11 | 98765 |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-08-05 | |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2020-08-05 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-08-05 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-08-05 | |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-05-13 | |
| TEAS EXTENSION RECEIVED | 2020-05-11 | |
| EXTENSION 1 GRANTED | 2020-05-11 | 98765 |
| EXTENSION 1 FILED | 2020-05-11 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-11-12 | |
| PUBLISHED FOR OPPOSITION | 2019-09-17 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-09-17 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-08-28 | |
| ASSIGNED TO LIE | 2019-08-13 | 70138 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-08-06 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-08-02 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-08-01 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-08-01 | 88889 |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-04-26 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-04-26 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-04-24 | 6325 |
| NON-FINAL ACTION WRITTEN | 2019-04-24 | 92833 |
| NON-FINAL ACTION E-MAILED | 2019-04-24 | 6325 |
| ASSIGNED TO EXAMINER | 2019-04-19 | 92833 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-03-05 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CTX130 97635360 not registered Live/Pending |
CRISPR Therapeutics AG 2022-10-17 |
 CTX130 88296767 not registered Live/Pending |
CRISPR Therapeutics AG 2019-02-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 